- Home
- YETI vs CPRX Comparison
YETI vs CPRX Comparison
Compare YETI & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YETI
- CPRX
- Stock Information
- Founded
- YETI 2006
- CPRX 2002
- Country
- YETI United States
- CPRX United States
- Employees
- YETI N/A
- CPRX N/A
- Industry
- YETI Recreational Games/Products/Toys
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- YETI Consumer Discretionary
- CPRX Health Care
- Exchange
- YETI Nasdaq
- CPRX Nasdaq
- Market Cap
- YETI 3.0B
- CPRX 2.8B
- IPO Year
- YETI 2018
- CPRX 2006
- Fundamental
- Price
- YETI $38.51
- CPRX $21.12
- Analyst Decision
- YETI Buy
- CPRX Strong Buy
- Analyst Count
- YETI 12
- CPRX 7
- Target Price
- YETI $45.33
- CPRX $31.14
- AVG Volume (30 Days)
- YETI 2.2M
- CPRX 1.1M
- Earning Date
- YETI 11-07-2024
- CPRX 11-06-2024
- Dividend Yield
- YETI N/A
- CPRX N/A
- EPS Growth
- YETI 217.19
- CPRX 114.68
- EPS
- YETI 2.31
- CPRX 1.18
- Revenue
- YETI $1,803,126,000.00
- CPRX $460,482,000.00
- Revenue This Year
- YETI $12.80
- CPRX $21.99
- Revenue Next Year
- YETI $7.38
- CPRX $17.95
- P/E Ratio
- YETI $16.64
- CPRX $17.92
- Revenue Growth
- YETI 13.62
- CPRX 32.17
- 52 Week Low
- YETI $33.41
- CPRX $13.00
- 52 Week High
- YETI $54.16
- CPRX $24.27
- Technical
- Relative Strength Index (RSI)
- YETI 50.79
- CPRX 45.27
- Support Level
- YETI $36.78
- CPRX $20.44
- Resistance Level
- YETI $42.42
- CPRX $21.63
- Average True Range (ATR)
- YETI 1.90
- CPRX 0.78
- MACD
- YETI 0.05
- CPRX -0.25
- Stochastic Oscillator
- YETI 56.60
- CPRX 17.75
About YETI YETI Holdings Inc.
YETI Holdings Inc is a designer, marketer, and distributor of premium products for the outdoor and recreation market sold under the YETI brand. The company offers products including coolers and equipment, drinkware, and other accessories. Its trademark products include YETI Tundra, Hopper, YETI TANK, Rambler, Colster, Rambler among others. The company distributes products through wholesale channels and through direct-to-consumer, or DTC, channels.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.